Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haopeng Sun

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Communications Chemistry|June 15, 2026
Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitorsLongjiang Qiao, Xinyu Li, Shuaishuai Xing, et al.
Oncogene|June 30, 2022
AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinomaDi Pan, Wanwan Yang, Yao Zeng, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 28, 2017
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's diseaseYao Chen, Jie Zhu, Jun Mo, et al.
Angewandte Chemie (International Ed. in English)|March 10, 2022
More than a Leaving Group: N-Phenyltrifluoroacetimidate as a Remote Directing Group for Highly α-Selective 1,2-cis GlycosylationXianglai Liu, Yingying Song, Ao Liu, et al.
European Journal of Medicinal Chemistry|May 15, 2014
Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I)Xiaoke Guo, Xianglei Ma, Qian Yang, et al.
Journal of Chemical Information and Modeling|August 14, 2013
Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modificationHaopeng Sun, Xiaoli Xu, Xiaowen Wu, et al.
European Journal of Medicinal Chemistry|May 5, 2024
Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's diseaseYing Chen, Weiting Zhang, Qi Li, et al.
Journal of Medicinal Chemistry|February 27, 2024
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule InhibitorsChengliang Sun, Yuling He, Gefei Wang, et al.
Bioorganic & Medicinal Chemistry|May 10, 2026
Development of tacrine-based multitarget-directed ligands as dual AChE/EGFR inhibitors with neuroprotective activityYuqing Wei, Ao Zhang, Weimin Qiu, et al.
European Journal of Medicinal Chemistry|April 30, 2019
Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradationMeiyang Xi, Yi Chen, Hongyu Yang, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Communications Chemistry|June 15, 2026
Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitorsLongjiang Qiao, Xinyu Li, Shuaishuai Xing, et al.
Oncogene|June 30, 2022
AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinomaDi Pan, Wanwan Yang, Yao Zeng, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 28, 2017
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's diseaseYao Chen, Jie Zhu, Jun Mo, et al.
Angewandte Chemie (International Ed. in English)|March 10, 2022
More than a Leaving Group: N-Phenyltrifluoroacetimidate as a Remote Directing Group for Highly α-Selective 1,2-cis GlycosylationXianglai Liu, Yingying Song, Ao Liu, et al.
European Journal of Medicinal Chemistry|May 15, 2014
Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I)Xiaoke Guo, Xianglei Ma, Qian Yang, et al.
Journal of Chemical Information and Modeling|August 14, 2013
Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modificationHaopeng Sun, Xiaoli Xu, Xiaowen Wu, et al.
European Journal of Medicinal Chemistry|May 5, 2024
Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's diseaseYing Chen, Weiting Zhang, Qi Li, et al.
Journal of Medicinal Chemistry|February 27, 2024
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule InhibitorsChengliang Sun, Yuling He, Gefei Wang, et al.
Bioorganic & Medicinal Chemistry|May 10, 2026
Development of tacrine-based multitarget-directed ligands as dual AChE/EGFR inhibitors with neuroprotective activityYuqing Wei, Ao Zhang, Weimin Qiu, et al.
European Journal of Medicinal Chemistry|April 30, 2019
Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradationMeiyang Xi, Yi Chen, Hongyu Yang, et al.
Pageof 17